1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Vaginismus: new trials by email Literature Review of Vaginismus trials Research Report on Vaginismus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction Botulinum toxin A 50u, Botulinum toxin A 100u, Botulinum toxin A 150u - Pelvic Pain, Dyspareunia | Phase 4 | Completed | EvergreenHealth | 20 | 2017-05-25 | 2021-06-10 |
| Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain Trigger Point Injections Triamcinolone Acetonide, Bupivacaine Hydrochloride, Pelvic Rehabilitation - Dyspareunia | Phase 4 | Unknown | University of Cincinnati | 36 | 2013-08-01 | 2013-12-30 |
Dyspareunia (2) · Pelvic Pain (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Diseases, Male (2) · Male Urogenital Diseases (2) · Mental Disorders (2) · Sexual Dysfunction, Physiological (2) · Sexual Dysfunctions, Psychological (2) · Urogenital Diseases (2) · Vaginal Diseases (2) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Botulinum Toxins, Type A (1) · Bupivacaine (1)
EvergreenHealth (1) · University of Cincinnati (1)
United States (2)
Mary South, MD (1) · Mia A. Swartz, MD (1)